Literature DB >> 104005

Dream phenomena induced by chronic levodopa therapy.

B Sharf, C Moskovitz, M D Lupton, H L Klawans.   

Abstract

Twenty-seven of eighty-eight (30.7%) Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy developed drug related dream phenomena. The patients reported three separate types of new dreams which we have classified as vivid dreams, night terrors and nightmares. These dreams are correlated to the duration of levodopa therapy although the mechanism of their production is unclear.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104005     DOI: 10.1007/bf01579073

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  REPORTS OF MENTAL ACTIVITY DURING SLEEP.

Authors:  A RECHTSCHAFFEN; P VERDONE; J WHEATON
Journal:  Can Psychiatr Assoc J       Date:  1963-12

2.  MENTAL ACTIVITY AT SLEEP ONSET.

Authors:  D FOULKES; G VOGEL
Journal:  J Abnorm Psychol       Date:  1965-08

3.  Patterns of sleep talking.

Authors:  A RECHTSCHAFFEN; D R GOODENOUGH; A SHAPIRO
Journal:  Arch Gen Psychiatry       Date:  1962-12

4.  A psychophysiological study of nightmares and night terrors. I. Physiological aspects of the stage 4 night terror.

Authors:  C Fisher; E Kahn; A Edwards; D M Davis
Journal:  J Nerv Ment Dis       Date:  1973-08       Impact factor: 2.254

5.  Effect of L-dopa on the sleep of man.

Authors:  R J Wyatt; T N Chase; J Scott; F Snyder; K Engleman
Journal:  Nature       Date:  1970-12-05       Impact factor: 49.962

6.  The serotonin-catecholamine-dream bicycle: a clinical study.

Authors:  R J Wyatt
Journal:  Biol Psychiatry       Date:  1972-08       Impact factor: 13.382

7.  Psychosis and other psychiatric manifestations of levodopa therapy.

Authors:  G G Celesia; A N Barr
Journal:  Arch Neurol       Date:  1970-09

Review 8.  Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in "dreaming sleep".

Authors:  R J Broughton
Journal:  Science       Date:  1968-03-08       Impact factor: 47.728

9.  Levodopa-induced psychosis: a kindling phenomenon.

Authors:  C Moskovitz; H Moses; H L Klawans
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

Review 10.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

View more
  19 in total

Review 1.  Sleep disturbances in Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Karina Bienfait
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 2.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

Review 3.  Sleep disorders in patients with Parkinson's disease: epidemiology and management.

Authors:  J P Larsen; E Tandberg
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  REM ocular activity in Parkinsonian patients chronically treated with levodopa.

Authors:  P Lavie; E Bental; H Goshen; B Sharf
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

5.  Dopaminergic control of sleep-wake states.

Authors:  Kafui Dzirasa; Sidarta Ribeiro; Rui Costa; Lucas M Santos; Shih-Chieh Lin; Andres Grosmark; Tatyana D Sotnikova; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

Review 6.  Drug-induced sleep disturbances. Focus on nonpsychotropic medications.

Authors:  M Novak; C M Shapiro
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

7.  Sleep Disorders in the Elderly.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2001-01       Impact factor: 3.598

8.  Auditory inhibition of rapid eye movements and dream recall from REM sleep.

Authors:  Katrina Stuart; Russell Conduit
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

Review 9.  Visual hallucinations in the elderly associated with the use of levodopa.

Authors:  A K Banerjee; P G Falkai; M Savidge
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

10.  Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.

Authors:  Luigi De Gennaro; Olimpia Lanteri; Fabrizio Piras; Serena Scarpelli; Francesca Assogna; Michele Ferrara; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Hum Brain Mapp       Date:  2015-12-24       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.